Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Communications Biology|May 3, 2019
The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survivalJing Zhang, Francesca P Caruso, Jason K Sa, et al.
Annals of Surgical Oncology|July 14, 2026
Postoperative Complications and Long-Term Cardiovascular Risk After Gastrectomy for Gastric CancerKyungduk Hurh, Junhyun Kwon, Ji-Hyeon Park, et al.
Genome Medicine|January 26, 2021
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trialSeung Tae Kim, Jason K Sa, Sung Yong Oh, et al.
International Journal of Molecular Sciences|April 10, 2019
Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with RUNX1-RUNX1T1 FusionJae Won Yun, Yoon Kyung Bae, So Yeong Cho, et al.
Cancers|August 3, 2019
Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma ModelsMijeong Lee, Yeon-Soo Kim, Kyoungmin Lee, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 4, 2023
Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcomaJae Ryoung Hwang, Young-Jae Cho, Ji-Yoon Ryu, et al.
International Journal of Molecular Sciences|September 14, 2017
Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI DomainHyunkyu Park, Donggeon Kim, Eunmi Kim, et al.
Stem Cell Reviews and Reports|November 5, 2021
Effects of Long-Term In Vitro Expansion on Genetic Stability and Tumor Formation Capacity of Stem CellsHyun Nam, In-Hee Lee, Jason K Sa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2020
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring HRAS MutationsHye Won Lee, Jason K Sa, Antonio Gualberto, et al.
Pageof 9